Alan Yeomans

home / authors / alan-yeomans

Articles

Site Logo

The Transformation of Clinical Trials from Writing on Papyrus to the World of Technology

Jules T. Mitchel, MBA, PhD;Greg Gogates;Alan Yeomans;Tai Xie, PhD;Luis A. Rojas, PhD;Jonathan Helfgott;Vadim Tantsyura
January 3rd 2022

New requirements must be put in place to ensure data quality and integrity.

Site Logo

When Should the Audit Trail Begin?

Jules Mitchel, PhD;Yumi Sugiura;Valdo Arnera, MD;Greg Gogates;Alan Yeomans;Devry Spreitzer;Suzanne Bishop
June 16th 2021

A discussion of the regulatory history behind audit trails and its interpretation as it relates to clinical research data originating or residing in EDC or eCOA systems.

Screen Shot 2019-07-08 at 4.01.10 PM.png

Keeping Up with the Regulatory Expectations

Jules T. Mitchel, MBA, PhD;Alan Yeomans;Ioannis Karageorgos;Suzanne Bishop;Pat Beers-Block;Devry Speitzer;Manuela Hornberger;Valdo Arnera;Evan Grunbaum;Mireille Muller;Cinzia Piccini;Neil Konopka
July 8th 2019

i11418829221647.jpg

The Future of ePRO Platforms

Alan Yeomans
December 1st 2014

It is tempting to imagine the use of the patient's own mobile computing platform for collection of patient-reported outcomes (PROs).

fig1-833920-1408529842065.png

The Future of ePRO Platforms

Alan Yeomans
January 28th 2014

It is tempting to imagine the use of the patient's own mobile computing platform for collection of patient reported outcomes.

Latest Updated Articles

Lightship’s Approach to Accessible, Representative, and Impactful Clinical Trials
Published: February 13th 2025 | Updated: March 4th 2025
Lightship’s Approach to Accessible, Representative, and Impactful Clinical Trials
Accelerate Inclusive Enrollment and Delivery with Lightship
Published: February 19th 2025 | Updated: February 26th 2025
Accelerate Inclusive Enrollment and Delivery with Lightship
How Vaccine Trials Could be Affected by Potential Policy Changes
Published: May 8th 2025 | Updated: May 21st 2025
How Vaccine Trials Could be Affected by Potential Policy Changes
Published: February 3rd 2025 | Updated: May 21st 2025
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
Published: February 3rd 2025 | Updated: May 21st 2025
Data-Driven Insights can Optimize Clinical Trial Site Selection
Published: February 3rd 2025 | Updated: May 21st 2025
Upping the Migraine Intelligence Quotient: RWD sheds light on prevalence rates, providers and treatment variation
© 2025 MJH Life Sciences

All rights reserved.